USA — Pharmaceutical company Bristol-Myers Squibb (BMS) has once again expanded its collaboration with Evotec, a drug discovery and development company. BMS has paid another US$50 million upfront to deepen…
Read MoreTag: Bristol Myers Squibb
Pricing hurdles force Bristol Myers to abandon plans for launching new cancer drug in Germany
GERMANY — Bristol Myers Squibb, following its European approval last September, has announced that it will not be launching Opdualag, an infusion of Opdivo and new antibody relatlimab, in Germany…
Read MoreBristol Myers buys Turning Point Therapeutics for US$4B, strikes up Roche rivalry
UNITED KINGDOM – Bristol Myers Squibb has acquired Turning Point Therapeutics in a US$4.1 billion deal and a new cancer asset slated to hit the markets next year, setting in…
Read MoreFDA approves Bristol Myers’ immunotherapy for advanced melanoma
USA – Bristol-Myers Squibb (BMS) announced that the first drug in a new class of cancer immunotherapies has been approved by US FDA as an initial treatment for advanced melanoma,…
Read MoreBMS faces competition as Teva launches first Revlimid generic in US
USA – Teva has launched its generic version of Bristol Myers Squibb’s Revlimid (lenalidomide) in the United States on Monday, making it the country’s first generic version of the cancer…
Read MoreLilly, Evotec partner to develop drugs for metabolic diseases
USA – Eli Lilly and Company has announced a drug discovery collaboration with Evotec in the field of metabolic diseases, with a focus on kidney diseases and diabetes. The three-year…
Read MoreBristol Myers Squibb’s Orencia becomes first drug approved for preventing graft-versus-host disease
USA – The US Food and Drug Administration (FDA) has given Orencia approval as a preventative therapy for acute graft-versus-host disease (GVHD) in combination with certain immunosuppressants. Orencia is the…
Read MoreNew warnings added to the labels of arthritis medications amid JAK medications safety reviews
USA – The Food and Drug Administration (FDA) has added strictest warnings to the labels of JAK inhibitors, a class of drugs used to treat arthritis manufactured by Pfizer, Eli…
Read More